From: Medicinal, nutritional, and nutraceutical potential of Sparassis crispa s. lat.: a review
Chemical constituents | Properties | Reference |
---|---|---|
Indole, tryptamine, melatonin, gentisic acid, gallic acid, p-hydroxybenzoic acid, o-cumaric acid, caffeic acid, protocatechuic acid, syryngic acid, and ergosterol | Antioxidant activity | Kawagishi et al. (2007) |
Crude polysaccharides | Â | Nowacka-Jechalke et al. (2021) |
alkaliphilic esterase | used as a biocatalyst in the pharmaceutics, food, and chemical industries | Chandrasekaran et al. (2011) |
Crude polysaccharides | Anticancer activity, | Nowacka-Jechalke et al. (2021) |
1,3-β-D glucan | Anticancer activity, | Ohno et al. (2000) |
 | used in cancer treatment | Harada et al. (2006) |
polysaccharide fractions of 1,3 β-glucan | antitumor activity | Ohno et al. (2000) |
the β-glucan fraction CA1 | Anticancer activity | Ohno et al. (2002) |
3 novel phthalides- hanabiratakelide A (1), B (2), and C (3) | Antiallergic against rhinitis | Yoshikawa et al. (2010) |
Sparoside A | Antiallergic against rhinitis | Wang et al. (2019) |
β-glucan | wound healing capacity | Kimura et al. (2013) |
Enhances increased production of adiponectin | Antidiabetic: regulates glucose levels and fatty acid breakdown | Yamamoto and Kimura (2010), |
Xanthoangelol, 2 chalcones, and 4-hydroxyderricin | Anti-bacterial activity | Hayashi et al. (2008) |
Sparassol and the other two were identified as incompletely determined methyl-dihydroxy-methoxy-methylbenzoate and methyl orsellinate | Anti-fungal activity (against Candida albicans) | Woodward et al. (1993) |
Enhances NO production | Anti-hypertensive activity | Yoshitomi et al. (2011) |